ライフサイエンスコーパス: device

1 ng catalysts that can thrive in an assembled device.

2 ing for further re-growth of the deep UV-LED device.

3 ut the need for surgical implantation of any device.

4 mission and receiving of signals through the device.

5 onse and electroluminescence within a single device.

6 icantly higher with the repositionable Lotus device.

7 a home-based multichannel cardiorespiratory device.

8 rs to reduce the dark current density of the device.

9 on beam through a two-stage plasma insertion device.

10 ipitation in a glass capillary microfluidics device.

11 0 microwells, for a total of 74240 wells per device.

12 ble products without the need for a read-out device.

13 netized toroidal plasma in the KSTAR tokamak device.

14 gnetic flux and producing a highly inductive device.

15 l charge-transport layers in phototransistor devices.

16 tries, specifically paper-based microfluidic devices.

17 possibilities in soft robotics and wearable devices.

18 ptoelectronic materials and high performance devices.

19 r use in flexible and transparent electronic devices.

20 toelectronic, photonic, and quantum photonic devices.

21 nless quantum Hall edge states in electronic devices.

22 well as the parallel development of cooling devices.

23 sing breakdown voltages of Ga2O3 based power devices.

24 ructures and their application in functional devices.

25 rials that are promising for spin-mechanical devices.

26 ing, drug delivery, catalysis, and nanoscale devices.

27 xploitation of their DW motion in spintronic devices.

28 achieve flexibility of functional electronic devices.

29 cally significant difference between the two devices.

30 ay enable quantum transport measurements and devices.

31 cies determine the function of materials and devices.

32 cantly increasing the dynamic range of these devices.

33 the first spontaneously formed Pancharatnam devices.

34 mporally responsive patterning, and wearable devices.

35 to compare the long-term outcomes with both devices.

36 o realize hybrid topological superconducting devices.

37 ce of even-denominator FQH in dual-gated BLG devices.

38 ation of flexible and disposable electronics devices.

39 ient self-organized fabrication of practical devices.

40 ls in novel electronic and energy harvesting devices.

41 ute to further developing higher performance devices.

42 articular for a new generation of electronic devices.

43 nts them being used in many biotechnological devices.

44 heir utility in the construction of flexible devices.

45 relatively warm temperatures in microfluidic devices.

46 or realizing various low-dimensional quantum devices.

47 FETs), solar cells or other light harvesting devices.

48 ency of current thermoelectric materials and devices.

49 considered in the design of TiO2-containing devices.

50 developing fast and efficient optoelectronic devices.

51 cells that will increase the total weight of devices.

52 as the template, and an integral part of the devices.

53 element, it is widely used in semiconductor devices.

54 ensional microfluidic paper-based analytical devices (3D-muPADs) are an evolution of single layer dev

55 to date, there are no commercially available devices able to obtain ultra-wide-field OCT or OCTA imag

56 This fluidic device allows for the dynamic treatment of spheroids acr

57 Our device allows high-throughput approaches, patterning dif

58 The device allows the simultaneous loading of cells into 16

59 However, using one of these devices alone, some common and harmless substances show

60 The realization of acoustic devices analogous to electronic systems, like diodes, tr

61 We report a smartphone-based device and associated imaging-processing algorithm to ma

62 ted in a range of microelectronic or optical devices and applications.

63 Developments in microscale devices and bioprinted 3D tissues are beginning to suppl

64 ility of using them in futuristic electronic devices and can provide a physical platform for the real

65 a plant, we manufactured organic electronic devices and circuits in vivo, leveraging the internal st

66 fication methods in point-of-care diagnostic devices and devices to be used in resource-limited setti

67 methods do not allow fabrication of photonic devices and functional microelements directly inside sil

68 croenvironments can be used to develop novel devices and methods in protein biophysics for sample man

69 the performance of paper-based microfluidic devices and permit the design of cellular assays, which

70 (3D-muPADs) are an evolution of single layer devices and they permit effective sample dispersion, ind

71 medical implants, reconfigurable electronic devices and/or temporary functional systems.

72 omplicated trabeculectomy, glaucoma drainage device, and cycloablative procedure.

73 d removal of the Linx sphincter augmentation device, and to report the results of 1-stage laparoscopi

74 that had exclusive use of embolic-protection devices, and that compared CAS against CEA for the treat

75 rnal quantum efficiency for mid- and deep-UV device application.

76 tools and materials to study the physics and device applications associated with chiral ordering and

77 to fully exploit their enormous potential in device applications, it is essential to optimize epitaxi

78 design for high efficiency mid- and deep-UV device applications.

79 t functionalities that have implications for device applications.

80 l idea with implications in designing all 2D device architecture as the structural phases in 2D mater

81 A new device architecture for fast organic transistor memory i

82 tic approaches for the design of alternative device architectures and approaches.

83 ctrode, which imposes restrictions on sensor device architectures and results in added expense, poore

84 l role in semiconductor devices, but in many device architectures they are nanostructured, disordered

85 In addition, Se devices are air-stable, non-toxic, and extremely simple

86 ssed, challenges for the application in real devices are analyzed, and strategies for circumventing d

87 Novel living devices are further demonstrated, enabled by 3D printing

88 al circulating tumor cells from blood, these devices are ineffective at capturing CTC clusters, incap

89 the photoactive layer, glass-glass laminated devices are reported, which sustain 80% of their "post b

90 Emerging micro-scale medical devices are showing promise, whether in delivering drugs

91 (2 puffs), administered through the Respimat device as add-on to background therapy.

92 hydrocarbon conversion in an electrochemical device at lower than normal reforming temperatures.

93 or shape of ablations created by the bipolar device at the different flow rates (P > .05 for all outc

94 y help pair the right patient with the right device at the right time.

95 electrically controlled nonlinear polariton devices at room temperature.

96 We introduce a novel cell retention device based on inertial sorting for perfusion culture o

97 ew possibilities for developing phase-change devices based on atomically thin membranes.

98 opment of lateral flow assays and analytical devices based on paper microfluidics.

99 the design of a set of living materials and devices based on stretchable, robust, and biocompatible

100 Here, the population quantified from mobile device-based population activity patterns was used to pr

101 Dismantling these devices before ELV shredding, as well as postshredder tr

102 erfaces play a crucial role in semiconductor devices, but in many device architectures they are nanos

103 imilar in control subjects and patients with devices, but there was a correlation between lesion volu

104 res, decreasing the series resistance of the device by 5x.

105 prove the sensitivity of rare cell isolation devices by increasing the processed whole blood volume.

106 This device can successfully realize a potential match betwee

107 trategies through which miniaturized optical devices can be monolithically fabricated on light-emitti

108 dge that now we have demonstrated that these devices can be successfully operated in superfluid (4)He

109 The use of cardiac implantable electronic devices (CIED) is increasing, and their associated infec

110 edures are less rigorous than those for drug/device clinical trials.

111 als for magnetic data storage and spintronic devices, compounds that allow a tailoring of magnetic do

112 ctor nanostructures holds promise for future device concepts in optoelectronic and spin-based technol

113 The device consists of a compact 44 mm drift tube with a tri

114 Microfluidic devices constructed using low cost materials presents as

115 We designed a device containing an array of electrically driven plasmo

116 ltiplexed deterministic lateral displacement devices containing 1.5 million microfabricated features

117 Central venous access device (CVAD)-related thrombosis (CRT) is a common compl

118 ntly, a marker that is reliable, cheap, less device-dependent, and can be easily and repeatedly used

119 evelopment, and nucleic acid based biosensor device design.

120 the development of tables to compare various devices, despite which large standard errors were found

121 Although there are numerous devices developed to isolate individual circulating tumo

122 significant health implications for medical device development in the future that can be used for pr

123 the implant procedure: cardiac perforation, device dislocation, and femoral vascular access site com

124 on the imaging speed as digital micro-mirror devices (DMDs) generate grayscale patterns at a low refr

125 AP was obtained with the FibroScan 502 Touch device (Echosens, Paris, France).

126 Miniaturized quarter-wave plate devices empower spin to orbital angular momentum convers

127 Also, 3D-printed muSPE devices enabled fast emulsion breaking and solvent deasp

128 recommendation to use of embolic protection devices (EPD) for saphenous vein graft (SVG) interventio

129 of the study device relative to the control device (estimated success rates, 55.4% and 59.1%, respec

130 The devices exhibit a high open circuit voltage of 1.08 +/-

131 Assembled devices exhibit enhanced current stability and a maximal

132 that poly(3-hexylthiophene) electrochemical devices exhibit voltage-dependent heterogeneous swelling

133 The devices exhibited an operating voltage of 1 V, a thresho

134 his high quality AlN template: a deep UV-LED device fabricated and showed a strong single sharp elect

135 Devices fabricated from films formed via radiative therm

136 High mobility graphene field-effect devices, fabricated on the complex-oxide heterostructure

137 Device fabrication is applicable via current experimenta

138 inting will have on the future of analytical device fabrication, miniaturization, and functionalizati

139 e is to achieve a fully programmable quantum device featuring coherent adiabatic quantum dynamics.

140 l cells (MFCs) are novel bio-electrochemical device for spontaneous or single step conversion of biom

141 platforms, there is no compact microfluidic device for the complementary, fast, cheap, reusable and

142 Development of the CrossBoss and Stingray devices for antegrade dissection and reentry (ADR) of ch

143 due to the rapid development of microneedle devices for drug delivery applications into skin.

144 cost have encouraged physicians to use these devices for prompt medical decision making.

145 pill counts, and medication event-monitoring devices for self-administration.

146 been extensively used in the development of devices for the medical proposes due to properties such

147 , they could be useful in functionally agile devices: for example, creating and moving conducting wal

148 Planar photovoltaic devices from optimized ACI perovskite films yield a powe

149 nd challenges are identified for MOF-enabled device functionality and technological applications that

150 als to achieve new quasiparticle species and device functionality.

151 eratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation.

152 In all cases, the magnetic state of the device, generally set by the applied field, controls the

153 Microfluidic devices >500 mum, rapid mixing (71% +/- 12% after 5 mm,

154 The device has an 8 microm cut-off wavelength at 77 K and ex

155 Silica-based devices have been at the forefront of such innovations f

156 t area compared to conventional charge-based devices have made spin waves or magnon spintronics a pro

157 and seamless integration at a level current devices have yet to achieve.

158 show that our process can be used to create devices having an active-area of 1.5 cm(2) having an ind

159 r enables wireless powering of bioelectronic devices; however, Specific Absorption Rate and size limi

160 Because device implantation is not easily reversible, as well as

161 th and CVE rates was performed for ablation, device implantation, electrophysiology study, lead extra

162 competing risk of death, ventricular assist device implantation, or cardiac transplantation.

163 es, may be unsuitable for ventricular assist device implantation.

164 tients (88.6%) received CRT-D at the time of device implantation.

165 We tested the device in a group of healthy young subjects and a group

166 evaluates the reliability of a handheld NIR device in distinguishing fillets and patties of Atlantic

167 d size enables potential application of this device in wearable transdermal alcohol measurements.

168 of solvent using an in situ microextraction device in which solvent moves through the probe, drawing

169 ergy to power different sensors and analysis devices in a wide variety of in-vitro applications.

170 The use of TCS devices in children as a bridge to transplant has risen

171 l in enabling high-performance electro-optic devices in III-V semiconductor field.

172 tom-up assembly of structures and functional devices in the nanoscale.

173 t of functional and personalized holographic devices in the visible and near-infrared spectrum can be

174 step-by-step instructions to re-building the device, including a comprehensive parts list, 3D design

175 Novel intradermal devices, including intradermal adapters and disposable-s

176 traction was associated with a lower risk of device infection at 5 years relative to capping (adjuste

177 extraction was associated with lower risk of device infections at 5 years.

178 is an opportunist, often causing prosthetic device infections.

179 The BCI device integrates wearable, wireless, dry electroencepha

180 This low-cost wearable device is amenable to facilitating healthcare in low-res

181 The device is characterized in vitro by delivering gamma-ami

182 In this work, a microfluidic device is developed for in-situ analysis of pesticide co

183 A hybrid metamaterial/graphene device is implemented into an external cavity set-up all

184 tems, where the geometry and function of the device is not fixed at the point of fabrication.

185 A new approach to biosensing devices is demonstrated aiming an easier and simpler app

186 Scaling of nonlinear optical quantum devices is of significant interest to enable quantum dev

187 objects, 2D and 3D crystalline lattices and devices is prominent among them.

188 Although the safety of these electronic devices is still not fully known, there is evidence of t

189 At the heart of these devices is the internal motion of electrons through semi

190 essfully apply these materials in deformable devices, knowledge of their mechanical response to dynam

191 h end-stage HF after left ventricular assist device (LVAD)-induced remodeling to identify mechanisms

192 ieved for the flexible perovskite solar-cell devices made on an indium tin oxide/poly(ethylene tereph

193 PSI incorporation is of great scientific and device manufacturing interest.

194 Improved safety of left ventricular assist devices means that these are becoming more commonly used

195 The majority of devices (n = 144; 86%) underwent more than 1 postapprova

196 One adverse event unrelated to study devices occurred during the study (gastrointestinal blee

197 ; P<0.001), need for left ventricular assist device (odds ratio, 3.48; 95% confidence interval, 2.25-

198 material compositions are needed to produce devices of tailor made characteristics.

199 o arbitrary semiconductor absorbers, D(2)GIS devices offer a high-performance paradigm for imaging ac

200 eloping low-cost surface microfluidic mixing devices on open substrates.

201 stom 3D printing of functional materials and devices opens new routes for the biointegration of vario

202 ndent heterogeneous swelling consistent with device operation and electrochromism.

203 etries, with performance approaching that of devices optimized for each material individually.

204 e two-photon regime in silicon-based optical devices, or possess small nonlinearities.

205 erolimus-eluting durable polymer stent for a device-oriented composite clinical endpoint at 12 months

206 n control subjects and 5.6% in patients with devices (p = 0.25) Neurocognitive function was similar i

207 LoA) were used to evaluate agreement between device pairs.

208 ving the way for a cost-effective high power device paradigm on an Si CMOS platform are demonstrated.

209 The most common notable change in device parameters (>50% change from baseline) immediatel

210 d 51 continuous-flow left ventricular assist device patients who received secondary prophylaxis with

211 overstressed LEDs show irreversibly degraded device performance, possibly because ions initially on t

212 explored along with strategies for improving device performance.

213 site-specific attachment of biomolecules to device platforms.

214 The device potential of these 2D ferroelectric materials is

215 The device presented in this work is simple and effective fo

216 This device presents a feasible alternative for fractionating

217 As both the graphene and device principles are transferrable to arbitrary semicon

218 Specifically, the dual-plasmon device produces a net photocurrent whose polarity is det

219 PEEK SPME-TM devices proved to be robust and were therefore used to p

220 ed to clarify the necessary means to achieve device quantum efficiency higher than the state-of-the-a

221 However, those devices rarely accomplish commercial application due to

222 The electrical power output of the device reached its maximum value of 1.5 pW at a temperat

223 Our universal NV-based sensor device records single-spin NMR spectra with 13 Hz resolu

224 an independent task force formed to monitor device-related and drug-related safety events.

225 end point showed noninferiority of the study device relative to the control device (estimated success

226 tion in a low-cost, portable, and autonomous device remains challenging.

227 d with cardiovascular-implantable electronic device removal and reimplantation during the initial inf

228 Our device represents a way of implementing coupled spin-orb

229 This device requires no additional support or shielding durin

230 e harvesting of these electrons in practical devices rests on a series of electron transfer processes

231 Device retention was 100% at 24 months and 96% at 60 mon

232 raoperative and postoperative complications, device retention, and best-corrected visual acuity (BCVA

233 e B-KPro, with no significant differences in device retention, visual rehabilitation, or rates of com

234 and miconazole on S. cerevisiae through the device's time-dependent frequency shift and motional res

235 The parallel tandem device shows an improved photon-to-electron response ove

236 and the physical mechanisms, we also perform device simulations.

237 and 80 cm(2) V(-1) s(-1) for electrons) and device stability are improved due to the reduced trap de

238 ures, opening the door to new optomechanical device strategies.

239 Additionally, analysis of symmetric device structures reveals propagating polarization domai

240 to controlling the DW behaviour in nanoscale device structures.

241 This fully integrated proposed hand-held device successfully exhibited a wide cortisol-detection

242 V OC of over 1 V is recorded in photovoltaic devices, suggesting that ITCC has great potential for ap

243 ssay carried out in a segmental microfluidic device that allows studying the effect of anti-cancer dr

244 ed by a smartphone-assisted portable imaging device that can autonomously perform the necessary image

245 of a rapid and accurate point-of-care (PoC) device that can perform these measurements from a minute

246 y of an investigational optoacoustic imaging device that fuses laser optical imaging (OA) with graysc

247 sted a proof-of-concept NanoThermoMechanical device that has shown a maximum rectification of 10.9% a

248 We describe a microfluidic device that isolates and enumerates peripheral blood lym

249 dependent values of OAM and designed another device that performs this operation for elliptically pol

250 development of point-of-care testing (POCT) devices that can be applied in healthcare monitoring.

251 For some of the used devices the median ARD was even well below 10%.

252 hether treatment with mandibular advancement device, the main alternative to continuous positive airw

253 ment of pultrusion-based biomimetic spinning devices.The natural production of silks remains elusive

254 findings have implications for the choice of device therapy in patients with NICM.

255 Definite or probable device thrombosis occurred in 31 patients in the scaffol

256 Seventeen patients had either device thrombosis or ischemic stroke.

257 day 30 or use of a mechanical cardiac assist device through day 5.

258 day 5, or use of a mechanical cardiac assist device through day 5; and a two-component composite of d

259 he user to customize an equilibrium dialysis device to fit their own experiments by choosing membrane

260 e adapted a microfluidic constriction sorter device to separate a wide range of nucleic acid analytes

261 f the improved size resolution of the 8-pore devices to analyze in real time the assembly of Hepatiti

262 hods in point-of-care diagnostic devices and devices to be used in resource-limited settings.

263 ology, which can be scaled-out with parallel devices to enable larger scale operation.

264 are both of critical significance for these devices to operate with high efficiency and long-term st

265 mprovement over the best previous comparable devices under standard illumination conditions.

266 Moreover, photostability of photovoltaic devices up to 10-Suns is observed, which is a direct res

267 ell as the high healthcare costs inherent in device use, a clear understanding of the clinical benefi

268 ep-ultraviolet light-emitting diode (UV-LED) device using this AlN/patterned Si.

269 ept for monolayer MoS2 optoelectronic memory devices using artificially-structured charge trap layers

270 tive transport functionalities in chip-based devices using magnetic domain wall conduits.

271 propose here a new kind of light-harvesting devices using plasmonic nano-antenna gratings, that enha

272 s of instrumented cardiac microphysiological devices via multimaterial three-dimensional (3D) printin

273 Lowering device voltage to avoid this issue is hindered by an ina

274 Finally, the recessed SPME device was applied to an on-site application for the tis

275 The device was characterized in terms of cell retention capa

276 The most commonly used device was the CentriMag-PediMag system (65%), followed

277 A home-made microchip electrophoresis (MCE) device was used to quantitate two biologically important

278 A one-dimensional array of these devices was sufficient to demonstrate an efficient Hammi

279 Using the device, we obtain cell-cycle statistics for C. elegans v

280 rary to the state-of-the-art plasmonic logic devices, we use the phase of the wave instead of the int

281 Devices were interrogated before and after MRI with the

282 Two single-port devices were tested in each of 12 patients with type 1 d

283 hieved herein by using a three-point bending device which is capable of delivering well-defined mecha

284 In this paper, we present a photonic crystal device which performs both tasks simultaneously and is a

285 lopment of new sensory and neural prosthetic devices which are capable of more precise point stimulat

286 T-BQ determines the cycling stability of the device while PEDOT-AQ provides excellent reversibility f

287 We anticipate this microfluidic device will facilitate drug screening in a relevant micr

288 lators, the individual elements in realistic devices will always have residual interactions, which mu

289 state.The development of future computation devices will be aided by a better understanding of the p

290 Here, we study a cavity device with four embedded GaAs quantum wells hosting exc

291 he steady state of power generation, the EFC device with RVC-Au electrodes provided high volumetric p

292 for a new generation of electronic/photonic devices with currently inaccessible and likely unimagina

293 There is a growing demand for energy storage devices with high energy and high power densities, long-

294 is of significant interest to enable quantum devices with high performance.

295 fety end point at 30 days was 7.4% with both devices with no difference in all-cause mortality (Lotus

296 construction of sophisticated materials and devices with sizes similar to that of a bacterium using

297 Using capacitor devices with symmetric and uniform interfacial terminati

298 and providing the possibility of developing devices with unprecedentedly high time-bandwidth perform

299 ective for developing specific and sensitive devices with wide potential applications.

300 and modulate sound in one simple electronic device would open up a new world in acoustics.